Skip to main content

and
  1. No Access

    Article

    Identification of side population cells in human hepatocellular carcinoma cell lines with stepwise metastatic potentials

    To identify the side population (SP) cells from four hepatocellular carcinoma (HCC) cell lines with stepwise metastatic potentials.

    Guo-Ming Shi, Yang Xu, Jia Fan, Jian Zhou in Journal of Cancer Research and Clinical On… (2008)

  2. No Access

    Article

    Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications

    The 14-3-3 proteins are highly conserved molecules that are involved in many vital biologic processes and are associated with the progression of cancer. The role of 14-3-3ζ, a dimeric isoform of 14-3-3, in int...

    Chi Zhang, Li-**n Liu, Zhao-Ru Dong, Guo-Ming Shi, Jia-Bin Cai in Tumor Biology (2015)

  3. No Access

    Article

    Role of 5-hydroxymethylcytosine level in diagnosis and prognosis prediction of intrahepatic cholangiocarcinoma

    The loss of 5-hydroxymethylcytosine (5-hmC) has been identified as an epigenetic hallmark in several malignancies. However, its role in intrahepatic cholangiocarcinoma (ICC) is still unknown. Our study aims to...

    Zhao-Ru Dong, Chi Zhang, Jia-bin Cai, Peng-Fei Zhang, Guo-Ming Shi in Tumor Biology (2015)

  4. Article

    Open Access

    Overexpression of RNF38 facilitates TGF-β signaling by Ubiquitinating and degrading AHNAK in hepatocellular carcinoma

    RING finger protein 38 (RNF38), a member of the RNF protein family, has just emerged as a vital driver of cancer progression. However, the oncogenic mechanisms of RNF38 remain unexplored.

    Rui Peng, Peng-Fei Zhang, Xuan Yang in Journal of Experimental & Clinical Cancer … (2019)

  5. Article

    Open Access

    Circular RNA circTRIM33–12 acts as the sponge of MicroRNA-191 to suppress hepatocellular carcinoma progression

    Recently, the dysregulation of circular RNA (circRNA) have been shown to have important regulatory roles in cancer development and progression, including hepatocellular carcinoma (HCC). However, the roles of m...

    Peng-Fei Zhang, Chuan-Yuan Wei, **ao-Yong Huang, Rui Peng, Xuan Yang in Molecular Cancer (2019)

  6. Article

    Open Access

    Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis

    Amplification of chromosome 7q21-7q31 is associated with tumor recurrence and multidrug resistance, and several genes in this region are powerful drivers of hepatocellular carcinoma (HCC). We aimed to investig...

    **ao-Yong Huang, Peng-Fei Zhang, Chuan-Yuan Wei, Rui Peng, Jia-Cheng Lu in Molecular Cancer (2020)

  7. Article

    Open Access

    Cancer cell-derived exosomal circUHRF1 induces natural killer cell exhaustion and may cause resistance to anti-PD1 therapy in hepatocellular carcinoma

    Natural killer (NK) cells play a critical role in the innate antitumor immune response. Recently, NK cell dysfunction has been verified in various malignant tumors, including hepatocellular carcinoma (HCC). Ho...

    Peng-Fei Zhang, Chao Gao, **ao-Yong Huang, Jia-Cheng Lu, **ao-Jun Guo in Molecular Cancer (2020)

  8. Article

    Open Access

    CircMEMO1 modulates the promoter methylation and expression of TCF21 to regulate hepatocellular carcinoma progression and sorafenib treatment sensitivity

    Cirrhosis is a recognized risk factor for develo** hepatocellular carcinoma (HCC). Few studies have reported the expression profile of circRNAs in HCC samples compared to paratumour dysplastic nodule (DN) sa...

    Zhao-Ru Dong, Ai-Wu Ke, Tao Li, Jia-Bing Cai, Ya-fei Yang, Wei Zhou in Molecular Cancer (2021)

  9. Article

    Open Access

    Amplification of spatially isolated adenosine pathway by tumor–macrophage interaction induces anti-PD1 resistance in hepatocellular carcinoma

    Immune checkpoint blockade resistance narrows the efficacy of cancer immunotherapies, but the underlying mechanism remains elusive. Delineating the inherent mechanisms of anti-PD1 resistance is important to im...

    Jia-Cheng Lu, Peng-Fei Zhang, **ao-Yong Huang in Journal of Hematology & Oncology (2021)

  10. Article

    Open Access

    Current applications and future perspective of CRISPR/Cas9 gene editing in cancer

    Clustered regularly interspaced short palindromic repeats (CRISPR) system provides adaptive immunity against plasmids and phages in prokaryotes. This system inspires the development of a powerful genome engine...

    Si-Wei Wang, Chao Gao, Yi-Min Zheng, Li Yi, Jia-Cheng Lu in Molecular Cancer (2022)

  11. Article

    Open Access

    KRAS acting through ERK signaling stabilizes PD-L1 via inhibiting autophagy pathway in intrahepatic cholangiocarcinoma

    While the correlation between PD-L1 expression and KRAS mutation has been previously reported in other solid tumors such as non-small cell lung cancer (NSCLC), whether PD-L1 can be modulated by ERK signaling down...

    Zheng Gao, Jia-Feng Chen, **ao-Gang Li, Ying-Hong Shi in Cancer Cell International (2022)

  12. Article

    Open Access

    KSR2-14–3-3ζ complex serves as a biomarker and potential therapeutic target in sorafenib-resistant hepatocellular carcinoma

    Kinase suppressor of Ras 2 (KSR2) is a regulator of MAPK signaling that is overactivated in most hepatocellular carcinoma (HCC). We sought to determine the role of KSR2 in HCC pathogenesis.

    Chao Gao, Si-wei Wang, Jia-cheng Lu, **ao-qiang Chai, Yuan-cheng Li in Biomarker Research (2022)

  13. Article

    Open Access

    Correction: Circular RNA circMET drives immunosuppression and anti-PD1 therapy resistance in hepatocellular carcinoma via the miR-30-5p/snail/DPP4 axis

    **ao-Yong Huang, Peng-Fei Zhang, Chuan-Yuan Wei, Rui Peng, Jia-Cheng Lu in Molecular Cancer (2024)